Sandbox leucocytosis: Difference between revisions
No edit summary |
No edit summary |
||
Line 458: | Line 458: | ||
{| | {| | ||
|- | |- | ||
! colspan=" | ! colspan="3" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Surface Lesions of Oral Mucosa | ||
! colspan="1" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Localization | ! colspan="1" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Localization | ||
! colspan="1" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Differentiating features | ! colspan="1" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Differentiating features | ||
Line 467: | Line 467: | ||
| rowspan="16" style="background: #DCDCDC; padding: 5px; text-align: left;" | | | rowspan="16" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* White | * White | ||
| rowspan="11" | | | rowspan="11" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Epithelial | * Epithelial | ||
| | | style="background: #DCDCDC; padding: 5px; text-align: left;"| | ||
* Geographic tongue | * Geographic tongue | ||
| | | | ||
Line 478: | Line 478: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Hairy tongue | * Hairy tongue | ||
| | | | ||
Line 487: | Line 487: | ||
| | | | ||
|- | |- | ||
| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Leukoedema | * Leukoedema | ||
| | | | ||
Line 496: | Line 496: | ||
| | | | ||
|- | |- | ||
| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* White sponge nevus | * White sponge nevus | ||
| | | | ||
Line 505: | Line 505: | ||
| | | | ||
|- | |- | ||
| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Hairy leukoplakia | * Hairy leukoplakia | ||
| | | | ||
Line 514: | Line 514: | ||
| | | | ||
|- | |- | ||
| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Lichen planus | * Lichen planus | ||
| | | | ||
Line 523: | Line 523: | ||
| | | | ||
|- | |- | ||
| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Nicotinic stomatitis | * Nicotinic stomatitis | ||
| | | | ||
Line 532: | Line 532: | ||
| | | | ||
|- | |- | ||
| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Hyperkeratosis | * Hyperkeratosis | ||
| | | | ||
Line 541: | Line 541: | ||
| | | | ||
|- | |- | ||
| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Epithelial dysplasia | * Epithelial dysplasia | ||
| | | | ||
Line 550: | Line 550: | ||
| | | | ||
|- | |- | ||
| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Carcinoma in-situ | * Carcinoma in-situ | ||
| | | | ||
Line 559: | Line 559: | ||
| | | | ||
|- | |- | ||
| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Squamous cell carcinoma | * Squamous cell carcinoma | ||
| | | | ||
Line 568: | Line 568: | ||
| | | | ||
|- | |- | ||
| rowspan="2" | | | rowspan="2" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Surface debris | * Surface debris | ||
| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Candidiosis | * Candidiosis | ||
| | | | ||
Line 579: | Line 579: | ||
| | | | ||
|- | |- | ||
| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Burn | * Burn | ||
| | | | ||
Line 588: | Line 588: | ||
| | | | ||
|- | |- | ||
| rowspan="3" | | | rowspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Subepithelial | * Subepithelial | ||
| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Congenital keratotic cyst | * Congenital keratotic cyst | ||
| | | | ||
Line 599: | Line 599: | ||
| | | | ||
|- | |- | ||
| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Scar | * Scar | ||
| | | | ||
Line 608: | Line 608: | ||
| | | | ||
|- | |- | ||
| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Fordyce granules | * Fordyce granules | ||
| | | | ||
Line 617: | Line 617: | ||
| | | | ||
|- | |- | ||
| rowspan="20" | | | rowspan="20" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Pigmented | * Pigmented | ||
| rowspan="11" | | | rowspan="11" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Localized | * Localized | ||
| rowspan="3" | | | rowspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Intravascular | * Intravascular | ||
| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Hemangioma | * Hemangioma | ||
| | | | ||
Line 631: | Line 631: | ||
| | | | ||
|- | |- | ||
| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Varix | * Varix | ||
| | | | ||
Line 639: | Line 639: | ||
| | | | ||
|- | |- | ||
| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Kaposi sarcoma | * Kaposi sarcoma | ||
| | | | ||
Line 647: | Line 647: | ||
| | | | ||
|- | |- | ||
| rowspan="3" | | | rowspan="3" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Extravasated blood | * Extravasated blood | ||
| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Hematoma | * Hematoma | ||
| | | | ||
Line 657: | Line 657: | ||
| | | | ||
|- | |- | ||
| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Ecchymosis | * Ecchymosis | ||
| | | | ||
Line 665: | Line 665: | ||
| | | | ||
|- | |- | ||
| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Petechiae | * Petechiae | ||
| | | | ||
Line 673: | Line 673: | ||
| | | | ||
|- | |- | ||
| rowspan="4" | | | rowspan="4" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Melanocytic | * Melanocytic | ||
| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Oral melanocytic macule | * Oral melanocytic macule | ||
| | | | ||
Line 683: | Line 683: | ||
| | | | ||
|- | |- | ||
| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Nevus | * Nevus | ||
| | | | ||
Line 691: | Line 691: | ||
| | | | ||
|- | |- | ||
| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Melanoma | * Melanoma | ||
| | | | ||
Line 699: | Line 699: | ||
| | | | ||
|- | |- | ||
| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Ephelis | * Ephelis | ||
| | | | ||
Line 707: | Line 707: | ||
| | | | ||
|- | |- | ||
| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Tattoo | * Tattoo | ||
| | | | ||
Line 716: | Line 716: | ||
| | | | ||
|- | |- | ||
| rowspan="9" | | | rowspan="9" style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Diffuse | * Diffuse | ||
| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Hereditary | * Hereditary | ||
| | | | ||
Line 727: | Line 727: | ||
| | | | ||
|- | |- | ||
| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Addison's disease | * Addison's disease | ||
| | | | ||
Line 736: | Line 736: | ||
| | | | ||
|- | |- | ||
| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Heavy metal ingestion | * Heavy metal ingestion | ||
| | | | ||
Line 745: | Line 745: | ||
| | | | ||
|- | |- | ||
| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Peutz-Jeghers syndrome | * Peutz-Jeghers syndrome | ||
| | | | ||
Line 754: | Line 754: | ||
| | | | ||
|- | |- | ||
| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Neurofibromatosis | * Neurofibromatosis | ||
| | | | ||
Line 763: | Line 763: | ||
| | | | ||
|- | |- | ||
| | | style="background: #DCDCDC; padding: 5px; text-align: left;" | | ||
* Polyostotic fibrous dysplasia | * Polyostotic fibrous dysplasia | ||
| | | |
Revision as of 06:43, 24 January 2019
Disease | Presentation | Risk Factors | Diagnosis | Affected Organ Systems | Important features | Picture |
---|---|---|---|---|---|---|
Diseases predominantly affecting the oral cavity | ||||||
Oral Candidiasis |
|
|
|
Localized candidiasis
Invasive candidasis |
|
|
Herpes simplex oral lesions |
|
|
|
|
||
Aphthous ulcers |
|
|
|
|
|
|
Squamous cell carcinoma |
|
|
||||
Leukoplakia |
|
|
|
|
||
Melanoma |
|
|
|
|
||
Fordyce spots |
|
|
|
|
||
Burning mouth syndrome |
|
|
||||
Torus palatinus |
|
|||||
Diseases involving oral cavity and other organ systems | ||||||
Behcet's disease |
|
|
|
|||
Crohn's disease |
|
|
|
|||
Agranulocytosis |
|
|
||||
Syphilis |
|
|
|
|||
Coxsackie virus |
|
|
||||
Chicken pox |
|
|
|
|
||
Measles |
|
|
|
|
Surface Lesions of Oral Mucosa | Localization | Differentiating features | Diagnostic procedure | Treatment | ||||
---|---|---|---|---|---|---|---|---|
|
|
|
||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
|
|||||||
|
||||||||
|
|
|||||||
|
||||||||
|
||||||||
|
|
|
|
|||||
|
||||||||
|
||||||||
|
|
|||||||
|
||||||||
|
||||||||
|
|
|||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
|
|||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
|
|
||||||
|
|
|||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
|
|||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
|
|||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
|
|||||||
Soft Tissue Lesion | Localization | Differentiating features | Diagnostic procedure | Treatment | ||||
|
Benign | Epithelial |
|
|||||
|
||||||||
|
||||||||
Mesenchymal |
|
|||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
Salivary gland |
|
|||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
Cyst |
|
|||||||
|
||||||||
|
||||||||
|
||||||||
Malignant |
|
|||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
|
|||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
|
|||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
Type of cancer | Subtype | Epidemiology | Localization | Clinical features | Diagnostic procedures |
---|---|---|---|---|---|
Squamous cell carcinoma
|
Verrucous carcinoma |
|
|
|
Biopsy shows:
Thickened club-shaped papillae and blunt stromal invaginations of well-differentiated squamous epithelium with marked keratinization |
Lymphoepithelial carcinoma | 0.8-2% of all oral or oropharyngeal cancers |
|
|
Biopsy chows:
| |
Epithelial precursor lesions | --- | --- | Seen in the entire digestive tract |
|
Biopsy shows:
|
Proliferative verrucous leukoplakia and precancerous conditions | --- |
|
|
An aggressive form of oral leukoplakia with considerable morbidity and
strong predilection to malignant transformation |
Biopsy shows:
|
Papillomas | Squamous cell papilloma and |
|
Any oral site may be affected mostly:
|
Soft, pedunculated lesions formed by a cluster of finger-like fronds or a sessile, dome-shaped lesion with a nodular, papillary or verrucous surface | Biopsy shows:
|
Condyloma acuminatum | 2nd and 5th decade with a peak in teenagers and young adults |
|
Biopsy shows:
Several sessile, cauliflower-like swellings forming a cluster | ||
Focal epithelial hyperplasia | Disease of children, adolescents and young adults |
|
|
Biopsy shows:
| |
Granular cell tumor | --- |
|
|
|
Biopsy shows:
|
Keratoacanthoma | --- |
whites
men as in women |
|
|
Biopsy shows:
|
Papillary hyperplasia | --- | Affects all age groups | Palate | Asymptomatic nodular or papillary mucosal lesion | Biopsy shows:
|
Median rhomboid glossitis | --- | --- | Dorsum of the tongue at the junction of the anterior two thirds
and posterior third |
Forms a patch of papillary atrophy in the region of the
embryological foramen caecum |
Biopsy shows:
|
Salivary gland tumors | Acinic cell carcinoma |
|
Tumors usually
form non-descript swellings |
Biopsy shows:
| |
Mucoepidermoid carcinoma |
|
|
|
Low power microscopy shows low-grade tumor with both cystic and solid areas and an inflamed, fibrous stroma | |
Adenoid cystic carcinoma |
|
|
Predominantly solid variant shows peri- and intraneural invasion | ||
Epithelial-myoepithelial
carcinoma |
--- | --- | --- | --- | |
Clear cell carcinoma,
NOS |
--- | --- | --- | ||
Basal cell | Rare in minor glands | Asymptomatic, smooth or lobulated sub-mucosal masses | Microscopically similar to basal
cell adenocarcinomas of the major gland | ||
Cystadenocarcinoma | 32% developed in the minor glands |
|
Slow growing and painless but
some palatal tumors may erode the underlying bone causing sinonasal complex |
--- | |
Salivary duct carcinoma |
|
|
Tumors formed painless swellings but many in the palate can be painful and ulcerated or fungated with metastases to regional lymph nodes | The range of
microscopical appearances is similar to that seen in the major glands | |
Salivary gland adenomas | Pleomorphic adenoma | 40-70% of minor gland tumors |
|
Painless, slow growing, submucosal masses, but when | Biopsy shows cellular, and hyaline or plasmacytoid cell |
Myoepithelioma | 42% of minor gland tumors |
|
--- | --- | |
Basal cell adenoma | 20% of minor gland tumors | --- | They are histologically
similar to those in major glands. | ||
Cystadenoma | 7% of benign minor gland tumors | --- | --- | ||
Kaposi sarcoma | --- |
|
|
Biopsy of all 4 types show:
| |
Lymphangioma | --- |
|
Tongue |
|
Biopsy shows:
|
Ectomesenchymal chondromyxoid
tumour of the anterior tongue |
--- |
|
--- | Asymptomatic, slow growing solitary nodule in the anterior dorsal tongue | Biopsy shows:
|
Focal oral mucinosis (FOM) | --- |
|
Asymptomatic fibrous or cystic-like lesion | Histopathology is characterized by:
| |
Congenital granular cell epuli | --- |
|
Solitary, somewhat pedunculated fibroma-like lesion attached to the alveolar
ridge near the midline |
||
Hematolymphoid tumors | Non-Hodgkin lymphoma | Second most common cancer of the oral cavity |
|
NHL of the lip presents with:
|
Biopsy shows:
|
Langerhans cell histiocytosis | --- |
and |
Common oral symptoms
include:
|
Biopsy shows ovoid Langerhans cells
with deeply grooved nuclei, thin nuclear membranes and abundant eosinophilic cytoplasm | |
Hodgkin lymphoma | --- |
|
Most patients present with localized disease (stage I/II), with
|
--- | |
Extramedullary myeloid
sarcoma |
--- | Isolated tumor-forming intraoral mass | Biopsy shows an Indian-file pattern of infiltration | ||
Follicular dendritic cell
sarcoma / tumour |
|
|
The patients usually
present with a painless mass |
Biopsy usually exhibits
borders and comprises:
| |
Mucosal malignant melanoma | --- |
|
80% arise:
Others:
|
|
|